Order Article Reprints

Othman I, Moossavi SZ, Bayati S, Chang YS, Sanjoy S, Grzyb K, Sy E, Cropper K, Kassir S, Sabry W. Ibrutinib in Elderly Patients with Chronic Lymphocytic Leukemia: Adverse Event Incidence, Management, and Outcomes in a Canadian Real-World Setting. Current Oncology. 2025; 32(6):296. https://doi.org/10.3390/curroncol32060296

Othman, Ibraheem, Seyedeh Zahra (Mona) Moossavi, Samaneh Bayati, Yi Sin Chang, Shubrandu Sanjoy, Karolina Grzyb, Eric Sy, Kayla Cropper, Sandy Kassir, and Waleed Sabry. 2025. "Ibrutinib in Elderly Patients with Chronic Lymphocytic Leukemia: Adverse Event Incidence, Management, and Outcomes in a Canadian Real-World Setting" Current Oncology 32, no. 6: 296. https://doi.org/10.3390/curroncol32060296

Othman, I., Moossavi, S. Z., Bayati, S., Chang, Y. S., Sanjoy, S., Grzyb, K., Sy, E., Cropper, K., Kassir, S., & Sabry, W. (2025). Ibrutinib in Elderly Patients with Chronic Lymphocytic Leukemia: Adverse Event Incidence, Management, and Outcomes in a Canadian Real-World Setting. Current Oncology, 32(6), 296. https://doi.org/10.3390/curroncol32060296